About
SOCIUM develops drug discovery and development services and phosphorylation analysis services for pharmaceutical and research customers. It is based in Tokyo, Japan, with a laboratory in Fujisawa, Kanagawa.
Services
Drug Discovery & Development
Uses drug repositioning and an in-house platform to identify and develop drug seeds and new indications for drugs.
Drug Discovery Consulting
Provides consulting for drug discovery challenges using proprietary AI, computational science, and phosphorylation analysis technologies.
Phosphorylation Analysis Service
Provides Phospho-Totum, a comprehensive phosphorylation array analysis platform that measures phosphorylation, kinase activity scores, and pathway activity scores.
- What to send
- Cell lysate · Message in the contact form · Samples with protein concentration in the range of 100–200 μg/L
Capabilities
- Assays and studies
- Phosphorylation array analysis · Kinase activity score analysis · Pathway activity score analysis · Off-target kinase analysis · Signal transduction pathway analysis
- Scale and capacity
- N=9 (3 sets per array × 3 arrays)
- Therapeutic areas
- Oncology · TDP43 protein-opathy
Instruments and platforms
- Proprietary protein array platform
- Fluorescence detection
- Measurement data analysis software
Modalities and species
- Modalities
- Drug repositioning · Drug discovery consulting · Phosphorylation array analysis · Kinase activity analysis · Pathway activity analysis
- Species and models
- Non-human species · Tissue · Blood · Cell lines
Industries served
- Pharmaceutical
- Oncology
- Rare disease
Company
- Founded
- 2017
Locations
- Based in
- Tokyo, Japan
- Sites
- Tokyo, Japan · Fujisawa, Japan · Fujisawa-shi, Kanagawa, Japan
- Serves
- Japan, United States, China, U.S.
Public records
- Parent company
- Socium IT B.V. · NL GLEIF
Similar labs
Work here? Claim this listing